Avian Influenza Summit provides an exceptional platform to enhance your corporate profile and create strong awareness of your products for the industries involved in:

• Vaccines Development • Diagnostics
• Surveillance
• Anti-virals
• Infection Control Equipmen

For enquiries / discussions on our sponsorship & exhibition opportunities,
please contact :

Ms. Audrey Wong,
Email: audrey.wong@ibcasia.com.sg
Tel: +65 6835 5134

Baxter Vaccines is part of the BioScience division of Baxter International Inc., a global healthcare company.

Baxter has developed an unique technology platform to manufacture Influenza vaccines at an industrial scale based on its proprietary serum protein free Vero cell technology, which can be used for the production of both interpandemic and pandemic vaccines such as H5N1.

At present, Baxter Vaccines markets 2 products, a vaccine against tick-borne encephalitis (FSME-IMMUN), as well as a group C meningococcal conjugate vaccine (NeisVac-C), and distributes a second generation, smallpox vaccine (ACAM 2000), which is licensed in the US by the FDA for government stockpiling.

QIAGEN is the leading provider of sample and assay technologies. Sample technologies are used to isolate DNA, RNA and proteins from any biological sample. Assay technologies are then used to make specific target biomolecules, such as the DNA of a specific virus, visible for subsequent analysis.

We have developed more than 500 consumable products and automated solutions. We sell these products to academic research markets, to leading pharmaceutical and biotechnology companies, to molecular diagnostics laboratories as well as to customers in applied testing markets such as forensics, animal or food testing, and pharmaceutical process control.

QIAGEN employs more than 2,600 people in over 30 locations worldwide